These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 22766229)

  • 21. Long-term follow-up of patients with obstructive hypertrophic cardiomyopathy treated with dual-chamber pacing.
    Megevand A; Ingles J; Richmond DR; Semsarian C
    Am J Cardiol; 2005 Apr; 95(8):991-3. PubMed ID: 15820173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term outcome of percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: a Scandinavian multicenter study.
    Jensen MK; Almaas VM; Jacobsson L; Hansen PR; Havndrup O; Aakhus S; Svane B; Hansen TF; Køber L; Endresen K; Eriksson MJ; Jørgensen E; Amlie JP; Gadler F; Bundgaard H
    Circ Cardiovasc Interv; 2011 Jun; 4(3):256-65. PubMed ID: 21540441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of right ventricular pacing site on left ventricular outflow tract obstruction in patients with hypertrophic obstructive cardiomyopathy.
    Gadler F; Linde C; Juhlin-Dannfeldt A; Ribeiro A; Rydén L
    J Am Coll Cardiol; 1996 Apr; 27(5):1219-24. PubMed ID: 8609346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors of outcome after alcohol septal ablation therapy in patients with hypertrophic obstructive cardiomyopathy.
    Chang SM; Lakkis NM; Franklin J; Spencer WH; Nagueh SF
    Circulation; 2004 Feb; 109(7):824-7. PubMed ID: 14967729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Atrial synchronous ventricular stimulation with reduced a.v. delay time as a therapeutic principle in hypertrophic obstructive cardiomyopathy].
    Duck HJ; Hutschenreiter W; Pankau H; Trenckmann H
    Z Gesamte Inn Med; 1984 Sep; 39(18):437-47. PubMed ID: 6542281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term effects of varying alcohol dosing in percutaneous septal ablation for obstructive hypertrophic cardiomyopathy: a randomized study with a follow-up up to 11 years.
    Veselka J; Tomašov P; Zemánek D
    Can J Cardiol; 2011; 27(6):763-7. PubMed ID: 22000583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathophysiology of hypertrophic cardiomyopathy determines its medical treatment.
    Musat D; Sherrid MV
    Anadolu Kardiyol Derg; 2006 Dec; 6 Suppl 2():9-17. PubMed ID: 17162264
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Maintenance therapy and various tests during follow-up of cardiomyopathies].
    Ogasawara S; Kimata S
    Nihon Naika Gakkai Zasshi; 1993 Feb; 82(2):231-4. PubMed ID: 8098350
    [No Abstract]   [Full Text] [Related]  

  • 29. Predictors of outcome in patients with suspected myocarditis.
    Kindermann I; Kindermann M; Kandolf R; Klingel K; Bültmann B; Müller T; Lindinger A; Böhm M
    Circulation; 2008 Aug; 118(6):639-48. PubMed ID: 18645053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcome of surgical myectomy after unsuccessful alcohol septal ablation for the treatment of patients with hypertrophic obstructive cardiomyopathy.
    Nagueh SF; Buergler JM; Quinones MA; Spencer WH; Lawrie GM
    J Am Coll Cardiol; 2007 Aug; 50(8):795-8. PubMed ID: 17707185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progressive decrease of outflow gradient and septum thickness after percutaneous alcoholization of the interventricular septum in hypertrophic obstructive cardiomyopathy.
    Airoldi F; Di Mario C; Catanoso A; Dharmadhikari A; Tzifos V; Anzuini A; Carlino M; Briguori C; Montorfano M; Vaghetti M; Tolaro S; Colombo A
    Ital Heart J; 2000 Mar; 1(3):200-6. PubMed ID: 10806987
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Understand your treatment options if you have HOCM. New devices and procedures are available to help manage hypertrophic obstructive cardiomyopathy.
    Heart Advis; 2010 Feb; 13(2):3. PubMed ID: 21192383
    [No Abstract]   [Full Text] [Related]  

  • 33. New concepts in hypertrophic cardiomyopathies, part II.
    Roberts R; Sigwart U
    Circulation; 2001 Oct; 104(18):2249-52. PubMed ID: 11684639
    [No Abstract]   [Full Text] [Related]  

  • 34. Lifestyle Modification and Medical Management of Hypertrophic Cardiomyopathy.
    Heitner SB; Fischer KL
    Cardiol Clin; 2019 Feb; 37(1):45-54. PubMed ID: 30447715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-surgical septal reduction therapy in hypertrophic cardiomyopathy.
    Cooper RM; Stables RH
    Heart; 2018 Jan; 104(1):73-83. PubMed ID: 28883035
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacological and non-pharmacological treatment of obstructive hypertrophic cardiomyopathy.
    Hidalgo LF; Naidu SS; Aronow WS
    Expert Rev Cardiovasc Ther; 2018 Jan; 16(1):21-26. PubMed ID: 29231770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pushing the Limits of Medical Management in HCM: A Review of Current Pharmacological Therapy Options.
    Stătescu C; Enachi Ș; Ureche C; Țăpoi L; Anghel L; Șalaru D; Pleșoianu C; Bostan M; Marcu D; Ovanez Balasanian M; Sascău RA
    Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonsurgical Treatment of Hypertrophic Cardiomyopathy.
    Henein MY; Gibson DG; Sigwart U
    Echocardiography; 1999 Aug; 16(6):611-616. PubMed ID: 11175199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of left ventricular global longitudinal strain in patients with hypertrophic cardiomyopathy and coronary artery disease.
    Gjergjindreaj M; Escolar E; Papadopoulos K; Mihos CG
    Int J Cardiovasc Imaging; 2024 Feb; 40(2):361-372. PubMed ID: 37950826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management strategy in 249 consecutive patients with obstructive hypertrophic cardiomyopathy referred to a dedicated program.
    Rothman RD; Baggish AL; O'Callaghan C; Lowry PA; Bhatt AB; MacRae CA; Yannekis G; Sanborn DM; Mela T; Yeh RW; Palacios I; Vlahakes GJ; Fifer MA
    Am J Cardiol; 2012 Oct; 110(8):1169-74. PubMed ID: 22766229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.